Guest: Andrew Garst, Co-Founder and Principal Scientist at Inscripta
What are the possibilities when we can make 200,000 genome edits in a single experiment? You don’t have to wait to find out, because Inscripta just announced that its desktop platform for multiplex genome engineering will soon let you do just that. Join SynBioBeta’s John Cumbers for a conversation with Andrew Garst, Co-Founder and Principal Scientist at Inscripta. We’ll discuss the challenges of gene engineering today, the tools and technologies to overcome them, and Andrew’s vision for digital genome engineering.